{"id":"W4379282039","doi":"10.1200/jco.2023.41.16_suppl.6050","title":"Phase I/II trial of durvalumab plus tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma: Final results.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Western University; Jewish General Hospital; London Health Sciences Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Durvalumab; Tremelimumab; Clinical endpoint; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Phases of clinical research; Head and neck cancer; Adverse effect; Radiation therapy; Nivolumab; Clinical trial; Immunotherapy; Cancer; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001884659,0.001937791,0.002414988,0.0004529447,0.000462645,0.0009767448,0.001198684,0.00157494,0.005732178],"category_scores_gemma":[0.0008850318,0.0007582678,0.001296317,0.0004308145,0.001020924,0.000871318,0.0004403382,0.002666366,0.001497022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001219225,"about_ca_system_score_gemma":0.00212166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00241472,"about_ca_topic_score_gemma":0.005979072,"domain_scores_codex":[0.9995536,0.0001944221,0.00002064502,0.00008333314,0.00004176805,0.0001061548],"domain_scores_gemma":[0.9993456,0.00008319067,0.0000953995,0.00005575956,0.00004283882,0.0003771407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.87305,0.04385449,0.002398632,0.0007162379,0.00138254,0.0001774044,0.0001595861,0.001644556,0.01773649,0.0002123087,0.00568034,0.05298739],"study_design_scores_gemma":[0.8085712,0.1826087,0.004638333,0.00002373214,0.0003743847,0.0001363577,0.00003070394,0.0007022183,0.001088882,0.0001517859,0.001656827,0.00001697638],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800237,0.00328548,0.0009441127,0.0008446876,0.0003947002,0.007062037,0.003395119,0.000248757,0.00380151],"genre_scores_gemma":[0.9721835,0.002697144,0.002992924,0.001890658,0.0003693937,0.006306872,0.006174561,0.0000659941,0.007318898],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005732178,"threshold_uncertainty_score":0.01917607,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2351455280784146,"score_gpt":0.5088777108746165,"score_spread":0.2737321827962019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}